AVITA Medical, Inc.
RCEL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $18 | $19 | $18 | $20 |
| % Growth | -0.5% | 0.6% | -5.8% | – |
| Cost of Goods Sold | $3 | $3 | $2 | $3 |
| Gross Profit | $15 | $16 | $16 | $16 |
| % Margin | 81.2% | 84.7% | 87.6% | 83.7% |
| R&D Expenses | $5 | $6 | $5 | $5 |
| G&A Expenses | $7 | $6 | $7 | $10 |
| SG&A Expenses | $21 | $21 | $21 | $25 |
| Sales & Mktg Exp. | $14 | $15 | $14 | $15 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $26 | $28 | $26 | $30 |
| Operating Income | -$11 | -$12 | -$10 | -$14 |
| % Margin | -60.5% | -63.9% | -54.1% | -70.6% |
| Other Income/Exp. Net | $1 | -$2 | -$2 | -$2 |
| Pre-Tax Income | -$10 | -$14 | -$12 | -$16 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$10 | -$14 | -$12 | -$16 |
| % Margin | -53.9% | -74.9% | -63% | -82.9% |
| EPS | -0.38 | -0.53 | -0.44 | -0.62 |
| % Growth | 28.3% | -20.5% | 29% | – |
| EPS Diluted | -0.38 | -0.53 | -0.44 | -0.62 |
| Weighted Avg Shares Out | 26 | 26 | 26 | 26 |
| Weighted Avg Shares Out Dil | 26 | 26 | 26 | 26 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$8 | -$12 | -$10 | -$15 |
| % Margin | -44% | -65.3% | -53.6% | -74.5% |